Decreased deaminase activity in A12-infected cells despite a high level of A3B protein. by Noémie Lejeune (9243785)

<i>CYB561</i> knockdown decreased the survival, proliferation, and migration rates of PC-3 cells. by Romie Angelo G. Azur (18547651)

<i>CYB561</i> knockdown decreased intracellular Fe²⁺ iron concentration and altered the expression of iron responsive genes in PC-3 cells. by Romie Angelo G. Azur (18547651)

Figure 2 from Ammonia Suppresses the Antitumor Activity of Natural Killer Cells and T Cells by Decreasing Mature Perforin by Joanna Domagala (21643925)

Rpl22L1 regulates 5-FU responsiveness in CRC. by Shuyun Rao (449181)

Subjects:

Rpl22L1 regulates the expression of DNA damage repair enzymes, MGMT and MLH1, which together with Rpl22L1 induction, contribute to poor prognosis. by Shuyun Rao (449181)

Subjects:

Figure 6 from Ammonia Suppresses the Antitumor Activity of Natural Killer Cells and T Cells by Decreasing Mature Perforin by Joanna Domagala (21643925)

Figure 7 from Ammonia Suppresses the Antitumor Activity of Natural Killer Cells and T Cells by Decreasing Mature Perforin by Joanna Domagala (21643925)

Figure 5 from Ammonia Suppresses the Antitumor Activity of Natural Killer Cells and T Cells by Decreasing Mature Perforin by Joanna Domagala (21643925)

“…<b>H,</b> The cells were loaded with the lysosomal fluorescent probes LysoPrime Green (the pH-resistant probe) and pHLys Red (the pH-sensitive probe; Dojindo Laboratories) and treated with increasing concentrations of NH₄Cl in the imaging medium or bafilomycin A as a control. …”

Figure S6. Treatment with a CCR4 antagonist decreases CCR4+ Tregs and increases T cell/Treg ratios in murine glioma. from CCL2 Produced by the Glioma Microenvironment Is Essential... by Alan L. Chang (14250716)

Functional Delivery Systems for Targeting Tumor Heterogeneity: Reversing Immunosuppression and Modulating Cancer-Immune Interplay by Di Han (618795)

Subjects:

Functional Delivery Systems for Targeting Tumor Heterogeneity: Reversing Immunosuppression and Modulating Cancer-Immune Interplay by Di Han (618795)

Subjects:

Functional Delivery Systems for Targeting Tumor Heterogeneity: Reversing Immunosuppression and Modulating Cancer-Immune Interplay by Di Han (618795)

Subjects:

Functional Delivery Systems for Targeting Tumor Heterogeneity: Reversing Immunosuppression and Modulating Cancer-Immune Interplay by Di Han (618795)

Subjects:

mRNA expression levels of NeuroD1 and GPX4 in clinical tumor samples. by Ping Huang (30439)

Subjects:

Changes in data-based resistance and data-based aggressiveness during therapy. by Kanyarat Jitmana (18693060)

Subjects:

Tumors from vehicle-treated mice were collected at the end of study, homogenized, and assessed for expression of FGFR1, vimentin, and β-actin. by Angela Abdollahi (15166230)

Subjects:

Cabozantinib treatment decreased microvessel density, but not proliferation and increased hypoxic stress in LuCaP 93 and LuCaP 173.1 patient-derived xenografts. by Mark P. Labrecque (10011469)

NeuroD1/GPX4 axis promotes HCC cell ferroptosis resistance and tumorigenic potential. by Ping Huang (30439)

Subjects:

NeuroD1 directly binds to the <i>GPX4</i> promoter and regulates its transcriptional activity in MHCC-97H cells. by Ping Huang (30439)

Subjects: